• NHS lifted Imbruvica restrictions after press campaign pharmaphorum
    August 22, 2018
    England’s National Health Service has lifted restrictions on Janssen’s blood cancer drug Imbruvica (ibrutinib), after a journalist who was suffering from chronic lymphocytic leukaemia (CLL) was denied access.
  • NHS scraps restriction on availability of J&J's Imbruvica in leukaemia patients pharmafile
    August 13, 2018
    The NHS has dropped a controversial restriction preventing leukaemia patients from accessing Johnson & Johnson’s tyrosine kinase inhibitor Imbruvica (ibrutinib), expanding its use to cover treatment-naïve patients with chronic lymphoblastic forms of the c
  • Biosimilars and generics saved NHS £324m last year pharmafile
    August 03, 2018
    The NHS watchdog, NHS Improvement, has revealed that the British National Health Service saved £324 million last financial year by using more cost effective biosimilars and generics, instead of more costly alternatives. The watchdog noted that the biosimi
  • RCEM calls for public action on A&E crisis pharmatimes
    July 24, 2018
    The Royal College of Emergency Medicine is urging patients to lobby MPs for action to address the “serious challenges” facing Emergency Departments across the UK.
  • ‘Workforce, technology and prevention’ NHS priorities, says Hancock pharmatimes
    July 24, 2018
    MP Matt Hancock has unveiled what he sees as “early priorities” in his new role as health and social care secretary: workforce, technology, and prevention.
  • Performance on A&E target slips further pharmatimes
    July 23, 2018
    NHS hospital performance against the four-hour A&E target stood at just 74.96 percent, well under the 95 percent target, for the week ending March 11th, show the most recent data from the Royal College of Emergency Medicine’s Winter Flow Project.
  • Hospitals failing to test for Lynch syndrome pharmatimes
    July 20, 2018
    Hospitals across the UK are failing to test all bowel cancer patients at the time of their diagnosis for a genetic condition called Lynch syndrome, which significantly increases the risk of developing cancer over a lifetime.
  • May backs new funding plan for NHS pharmatimes
    July 20, 2018
    Prime Minister Theresa May has voiced support for a new long-term funding plan for the National Health Service.
  • NHS to fund balloon pulmonary angioplasty in the UK pharmatimes
    July 19, 2018
    NHS England is funding a pioneering procedure that will improve treatment outcomes for patients with a lung disease called Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
  • Record numbers taking part in life sciences industry research pharmatimes
    July 19, 2018
    The number of people taking part in NHS clinical research studies sponsored by the life sciences industry has risen dramatically over the last year, show new figures by the National Institute for Health Research (NIHR).
PharmaSources Customer Service